Topotecan in the treatment of relapsed small cell lung cancer
Elisabeth QuoixService de Pneumologie, Hôpitaux Universitaires, Strasbourg, FranceAbstract: Small cell lung cancer (SCLC) represents about 15% to 20% of all lung cancers. Chemotherapy is the cornerstone of the treatment, cisplatin–etoposide combination being the most used...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-12-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/topotecan-in-the-treatment-of-relapsed-small-cell-lung-cancer-a2650 |